Skip to main content
Clinical Trials/IRCT201111288241N1
IRCT201111288241N1CompletedPhase 2

Comparison the effect of ondansetron and placebo on pruritus in hemodialysis patients

Vice chancellor for research and education0 sites70 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
70

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • Patients with chronic renal failure undergoing hemodialysis; willingness of patients for entry into the study; minimum age 18 years. Exclusion criteria: Patients with a history of skin or metabolic disease causing itching; Patients who received anti-pruritic medications two weeks before; pregnant women; People under age 18; non-cooperation Patients.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice chancellor for research and education

Similar Trials

Effect of ondansetron on pruritus in... | Clinical Trial